 Kintara Therapeutics Inc NASDAQ:KTRA OTCMKTS:DMPWW FRA:3DM, a biopharmaceutical company focused on the development of new solid tumor cancer therapies, has announced its addition to the Russell Microcap Index. The company said its addition will take place at the conclusion of the 2021 Russell Indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted on June 4. 